🚨 Loading... Read More

Novo Nordisk partners with OpenAI in weight loss drug race

Political Leaning Analysis
Left Center Right
Score: 0.00Center / Neutral

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates...


Story Timeline


Different Perspectives

ABC7 Los Angeles
1 article
ABC7 San Francisco
1 article
Al Jazeera English
3 articles
BBC Headlines
1 article
CNBC
1 article
DW All
1 article
DW Top
1 article
Euronews
1 article
Fox News
3 articles
La Libre (BE)
1 article
MSN
1 article
Mission Local
1 article
NBC Bay Area
1 article
NBC News
1 article
People.com
1 article
Reuters
1 article
SFGATE
1 article
San Francisco Chronicle
1 article
Seeking Alpha
1 article
Sky News (UK)
1 article
The Guardian
1 article
WIRED
1 article
WSJ
1 article
WUSA9
1 article
Washington Examiner
2 articles
Wired Business
1 article